Backgrounds of Speech Disorders in Children with Down Syndrome. An Early Logopedic Intervention
DOI:
https://doi.org/10.15225/PNN.2016.5.4.6Keywords
Down syndrome, speech disorders, neurologopedics, therapy for a childAbstract
Speech development of children with a Down syndrome is partly stunted or disturbed in comparison to healthy children’s speech, although, it is subjected to the same rules. The right speech development process of children with a Down syndrome (according to a child possibilities) can be provided by a well prepared program focused on stimulation of development and progress of speech in a complex curative and rehabilitative process. The exercises need to lead to the activation of a person and they should help to integrate with a society and, thanks to that, create conditions to the correct personality development. The aim of the study is to identify the causes that interfere with normal speech development of a child with Down syndrome including defects and anomalies in the anatomy and the dysfunction of the central and peripheral nervous system, and to present guidelines for a speech therapist working with a child with trisomy 21 in the first months of life. (JNNN 2016;5(4):162–167)
References
Watanabe J., Sugiura M., Miura N. et al. The human parietal cortex is involved in spatial processing of tongue movement-an fMRI study. Neuroimage. 2004;21(4):1289–1299.
Corfield D.R., Murphy K., Josephs O. et al. Cortical and subcortical control of tongue movement in humans: a functional neuroimaging study using fMRI. J Appl Physiol. 1999;86(5):1468–1477.
Mu L., Sanders I. Human Tongue Neuroanatomy: Nerve Supply and Motor Endplates. Clin Anat. 2010;23(7):777–791.
Rosenbaum S., Simon P. Childhood Speech and Language Disorders in the General U.S. Population. National Academies Press, Washington 2016.
Dennis M. Language disorders in children with central nervous system injury. J Clin Exp Neuropsychol. 2010;32(4):417–432.
Kirby A., Sugden D.A. Children with developmental coordination disorders. J R Soc Med. 2007;100(4):182–186.
Martin G.E., Klusek J., Estigarribia B., Roberts J.E. Language Characteristics of Individuals with Down Syndrome. Top Lang Disord. 2009;29(2):112–132.
Committee on the Evaluation of the Supplemental Security Income (SSI) Disability Program for Children with Speech Disorders and Language Disorders. Speech and Language Disorders in Children: Implications for the Social Security Administration’s Supplemental Security Income Program. National Academies Press, Washington 2016.
Hellbrügge T. Monachijska Funkcjonalna Diagnostyka Rozwojowa. Część II: Drugi i trzeci rok życia. Antykwa, Kraków 1995.
Hippolyte L., Iglesias K., Van der Linden M., Barisnikov K. Social reasoning skills in adults with Down syndrome: the role of language, executive functions and socio-emotional behaviour. J Intellect Disabil Res. 2010;54(8):714–726.
Boyd P.A., Loane M., Garne E., Khoshnood B., Dolk H., EUROCAT working group. Sex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancy. Eur J Hum Genet. 2011;19(2):231–234.
Torfs C.P., Christianson R.E. Anomalies in Down syndrome individuals in a large population-based registry. Am J Med Genet. 1998;77(5):431–438.
Stoll C., Dott B., Alembik Y., Roth M.-P. Associated congenital anomalies among cases with Down syndrome. Eur J Med Genet. 2015;58(12):674–680.
Liza-Sharmini A.T., Azlan Z.N., Zilfalil B.A. Ocular findings in Malaysian children with Down syndrome. Singapore Med J. 2006;47(1):14–19.
Stirn Kranjc B. Ocular abnormalities and systemic disease in Down syndrome. Strabismus. 2012;20(2):74–77.
Enders H., Schmaltz A., Apitz J. Zur Prognose von Patienten mit Morbus Down. Sozial Pädiatrie. 1990;12(12):882–888.
Ghaziuddin N., Nassiri A., Miles J.H. Catatonia in Down syndrome; a treatable cause of regression. Neuropsychiatr Dis Treat. 2015;11:941–949.
Mazurek D., Wyka J. Down syndrome-genetic and nutritional aspects of accompanying disorders. Rocz Panstw Zakl Hig. 2015;66(3):189–194.
Hatch-Stein J.A., Zemel B.S., Prasad D. et al. Body Composition and BMI Growth Charts in Children With Down Syndrome. Pediatrics. 2016. doi: 10.1542/peds. 2016-0541.
Dimopoulos K., Kempny A. Patients with Down syndrome and congenital heart disease: survival is improving, but challenges remain. Heart. 2016;102(19):1515–1517.
Martínez-Quintana E., Rodríguez-González F., Medina--Gil J.M., Agredo-Muñoz J., Nieto-Lago V. Clinical outcome in Down syndrome patients with congenital heart disease. Cir Cir. 2010;78(3):245–250.
Korenberg J.R., Chen X.N., Schipper R. et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci U S A. 1994;91(11):4997–5001.
Lana-Elola E., Watson-Scales S.D., Fisher E.M., Tybulewicz V.L. Down syndrome: searching for the genetic culprits. Dis Model Mech. 2011;4(5):586–595.
Wisniewski K.E., Schmidt-Sidor B. Postnatal delay of myelin formation in brains from Down syndrome infants and children. Clin Neuropathol. 1989;8(2):55–62.
Ábrahám H., Vincze A., Veszprémi B. et al. Impaired myelination of the human hippocampal formation in Down syndrome. Int J Dev Neurosci. 2012;30(2):147–158.
Olmos-Serrano J.L., Kang H.J., Tyler W.A. et al. Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination. Neuron. 2016;89(6):1208–1222.
Wisniewski K.E., Bobinski M. Hypothalamic abnormalities in Down syndrome. Prog Clin Biol Res. 1991;373:153–167.
Castells S., Beaulieu I., Torrado C., Wisniewski K.E., Zarny S., Gelato M.C. Hypothalamic versus pituitary dysfunction in Down’s syndrome as cause of growth retardation. J Intellect Disabil Res. 1996;40(6):509–517.
Ypsilanti A., Grouios G. Linguistic profile of individuals with Down syndrome: comparing the linguistic performance of three developmental disorders. Child Neuropsychol. 2008;14(2):148–170.
Styczek I. Logopedia. PWN, Warszawa 1983.
Grieco J., Pulsifer M., Seligsohn K., Skotko B., Schwartz A. Down syndrome: Cognitive and behavioral functioning across the lifespan. Am J Med Genet C Semin Med Genet. 2015;169(2):135–149.
Chapman R.S. Language learning in Down syndrome: the speech and language profile compared to adolescents with cognitive impairment of unknown origin. Downs Syndr Res Pract. 2006;10(2):61–66.
Limbrock G.J., Hoyer H., Scheying H. Regulation therapy by Castillo-Morales in children with Down syndrome: primary and secondary orofacial pathology. ASDC J Dent Child. 1990;57(6):437–441.
Korbmacher H.M., Limbrock J.G., Kahl-Nieke B. Long-term evaluation of orofacial function in children with Down syndrome after treatment with a stimulating plate according to Castillo Morales. J Clin Pediatr Dent. 2006;30(4):325–328.
Schuster-Amft C., Henneke A., Hartog-Keisker B. et al. Intensive virtual reality-based training for upper limb motor function in chronic stroke: a feasibility study using a single case experimental design and fMRI. Disabil Rehabil Assist Technol. 2015;10(5):385–392.
Fidler D.J., Hepburn S.L., Mankin G., Rogers S.J. Praxis skills in young children with Down syndrome, other developmental disabilities, and typically developing children. Am J Occup Ther. 2005;59(2):129–138.
Mendonca G.V., Pereira F.D., Fernhall B. Reduced exercise capacity in persons with Down syndrome: cause, effect, and management. Ther Clin Risk Manag. 2010;6:601–610.
Bruni M., Cameron D., Dua S., Noy S. Reported sensory processing of children with Down syndrome. Phys Occup Ther Pediatr. 2010;30(4):280–293.
Ayres A.J. Bausteine der kindlichen Entwicklung: Die Bedeutung der Integration der Sinne für die Entwicklung des Kindes. 3rd ed. Springer, Berlin 1998.
Gomez G.A., McLachlan R.W., Yap A.S. Productive tension: force-sensing and homeostasis of cell-cell junctions. Trends Cell Biol. 2011;21(9):499–505.
Wilken E. Sprachliche Förderung bei Kindern mit Down Syndrom. Bundesvereinigung Lebenshilfe. Plastische Chirurgie 1995.
Castillo-Morales R. Die orofaziale Regulationstherapie. Kommunikation. München: Plafum Verlag 1992.
Laws G., Bishop D.V. Verbal deficits in Down’s syndrome and specific language impairment: a comparison. Int J Lang Commun Disord. 2004;39(4):423–451.
Limbrock G.J., Fischer-Brandies H., Avalle C. Castillo-Morales’ orofacial therapy: treatment of 67 children with Down syndrome. Dev Med Child Neurol. 1991;33(4):296–303.
Limbrock G.J., Castillo-Morales R., Hoyer H., Stöver B., Onufer C.N. The Castillo-Morales approach to orofacial pathology in Down syndrome. Int J Orofacial Myology. 1993;19:30–37.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Stats
Number of views and downloads: 277
Number of citations: 0